Education
About Us
Working with TipRanks
Follow Us
OrthoPediatrics Corp (KIDS)
NASDAQ:KIDS
Total Valuation
OrthoPediatrics has a market cap or net worth of $403.24M. The enterprise value is $501.81M.
Market Cap$403.24M
Enterprise Value$501.81M
Share Statistics
OrthoPediatrics has 25,077,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding25,077,330
Owned by Insiders32.72%
Owned by Institutions21.16%
Financial Efficiency
OrthoPediatrics’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is -6.27%.
Return on Equity (ROE)-0.11
Return on Assets (ROA)-0.08
Return on Invested Capital (ROIC)-6.27%
Return on Capital Employed (ROCE)-0.06
Revenue Per Employee420.55K
Profits Per Employee-70.55K
Employee Count562
Asset Turnover0.46
Inventory Turnover0.48
Valuation Ratios
The current PE Ratio of OrthoPediatrics is ―. OrthoPediatrics’s PEG ratio is -3.45.
PE Ratio―
PS Ratio1.76
PB Ratio1.20
Price to Fair Value1.20
Price to FCF-26.10
Price to Operating Cash Flow-86.46
PEG Ratio-3.45
Income Statement
In the last 12 months, OrthoPediatrics had revenue of 236.35M and earned -39.65M in profits. Earnings per share was -1.69.
Revenue236.35M
Gross Profit172.66M
Operating Income-29.00M
Pretax Income-39.19M
Net Income-39.65M
EBITDA-29.00M
Earnings Per Share (EPS)-1.69
Cash Flow
In the last 12 months, operating cash flow was -4.85M and capital expenditures -11.11M, giving a free cash flow of -15.96M billion.
Operating Cash Flow-4.85M
Free Cash Flow-15.96M
Free Cash Flow per Share-0.64
Dividends & Yields
OrthoPediatrics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.66
52-Week Price Change-22.28%
50-Day Moving Average17.60
200-Day Moving Average19.18
Relative Strength Index (RSI)56.85
Average Volume (3m)196.93K
Important Dates
OrthoPediatrics upcoming earnings date is May 6, 2026, After Close (Confirmed).
Last Earnings DateFeb 26, 2026
Next Earnings DateMay 6, 2026
Ex-Dividend Date―
Financial Position
OrthoPediatrics as a current ratio of 5.55, with Debt / Equity ratio of 13.95%
Current Ratio5.55
Quick Ratio2.65
Debt to Market Cap0.12
Net Debt to EBITDA-0.99
Interest Coverage Ratio-4.84
Taxes
In the past 12 months, OrthoPediatrics has paid 460.00K in taxes.
Income Tax460.00K
Effective Tax Rate-0.01
Enterprise Valuation
OrthoPediatrics EV to EBITDA ratio is -15.36, with an EV/FCF ratio of -27.91.
EV to Sales1.88
EV to EBITDA-15.36
EV to Free Cash Flow-27.91
EV to Operating Cash Flow-91.82
Balance Sheet
OrthoPediatrics has $60.85M in cash and marketable securities with $48.36M in debt, giving a net cash position of $12.49M billion.
Cash & Marketable Securities$60.85M
Total Debt$48.36M
Net Cash$12.49M
Net Cash Per Share$0.50
Tangible Book Value Per Share$9.32
Margins
Gross margin is 73.05%, with operating margin of -12.27%, and net profit margin of -16.78%.
Gross Margin73.05%
Operating Margin-12.27%
Pretax Margin-16.58%
Net Profit Margin-16.78%
EBITDA Margin-12.27%
EBIT Margin0.00%
Analyst Forecast
The average price target for OrthoPediatrics is $25.57, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$25.57
Price Target Upside43.73% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast19.90%
EPS Growth Forecast-57.90%